Vericel Corporation (VCEL) - NASDAQ
From other sites
Company Description
Vericel Corp. engages in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two cell therapy products in the United States, Carticel (autologous cultured chondrocytes), an autologous... More
Sector: Healthcare
Industry: Biotechnology
Country: United States